| 000 | 01478 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512221655.0 | ||
| 264 | 0 | _c19840222 | |
| 008 | 198402s 0 0 ger d | ||
| 022 | _a0016-5751 | ||
| 024 | 7 |
_a10.1055/s-2008-1036717 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoeschen, K | |
| 245 | 0 | 0 |
_a[Oxytocin (OT) and 13,14-dihydro-15-keto-PGF2 alpha (PGFM) levels after intracervical administration of PGE2 gel combined with administration of beta mimetics; biochemical changes and clinical consequences]. _h[electronic resource] |
| 260 |
_bGeburtshilfe und Frauenheilkunde _cOct 1983 |
||
| 300 |
_a589-93 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aCervix Uteri |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aEthanolamines _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFenoterol _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyometrium _xdrug effects |
| 650 | 0 | 4 |
_aOxytocin _xblood |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aProstaglandins E _xadministration & dosage |
| 650 | 0 | 4 |
_aProstaglandins F _xblood |
| 700 | 1 | _aFuchs, A R | |
| 700 | 1 | _aRasmussen, A B | |
| 700 | 1 | _aFuchs, F | |
| 700 | 1 | _aSaling, E | |
| 773 | 0 |
_tGeburtshilfe und Frauenheilkunde _gvol. 43 _gno. 10 _gp. 589-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2008-1036717 _zAvailable from publisher's website |
| 999 |
_c6557807 _d6557807 |
||